Asymmetric synthesis of H1 receptor antagonist (R,R)-clemastine

The first asymmetric synthesis of ( R , R )-clemastine ( 1 ) has been accomplished by the coupling of ( R )-tertiary alcohol 2 and ( R )-chloroethylpyrrolidine 3 via O -alkylation. ( R )-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reage...

Full description

Saved in:
Bibliographic Details
Published inArchives of pharmacal research Vol. 38; no. 12; pp. 2131 - 2136
Main Authors Lee, Sun Young, Jung, Jung Wha, Kim, Tae-Hyun, Kim, Hee-Doo
Format Journal Article
LanguageEnglish
Published Seoul Pharmaceutical Society of Korea 01.12.2015
대한약학회
Subjects
Online AccessGet full text
ISSN0253-6269
1976-3786
1976-3786
DOI10.1007/s12272-015-0641-4

Cover

Abstract The first asymmetric synthesis of ( R , R )-clemastine ( 1 ) has been accomplished by the coupling of ( R )-tertiary alcohol 2 and ( R )-chloroethylpyrrolidine 3 via O -alkylation. ( R )-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. ( R )-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with l -homoserine lactone, in which racemization-minimized N -allylation and ring-closing metathesis were involved as key steps.
AbstractList The first asymmetric synthesis of (R,R)-clemastine (1) has been accomplished by the coupling of (R)-tertiary alcohol 2 and (R)-chloroethylpyrrolidine 3 via O-alkylation. (R)-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. (R)-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with L-homoserine lactone, in which racemization-minimized N-allylation and ring-closing metathesis were involved as key steps.
The first asymmetric synthesis of (R,R)-clemastine (1) has been accomplished by the coupling of (R)-tertiary alcohol 2 and (R)-chloroethylpyrrolidine 3 via O-alkylation. (R)-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. (R)-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with L-homoserine lactone, in which racemization-minimized N-allylation and ring-closing metathesis were involved as key steps.The first asymmetric synthesis of (R,R)-clemastine (1) has been accomplished by the coupling of (R)-tertiary alcohol 2 and (R)-chloroethylpyrrolidine 3 via O-alkylation. (R)-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. (R)-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with L-homoserine lactone, in which racemization-minimized N-allylation and ring-closing metathesis were involved as key steps.
The first asymmetric synthesis of (R,R)-clemastine (1) has been accomplished by the coupling of (R)-tertiary alcohol 2 and (R)-chloroethylpyrrolidine 3 via O-alkylation. (R)-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral a-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. (R)-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with L-homoserine lactone, in which racemization-minimized N-allylation and ring-closing metathesis were involved as key steps. KCI Citation Count: 5
The first asymmetric synthesis of ( R , R )-clemastine ( 1 ) has been accomplished by the coupling of ( R )-tertiary alcohol 2 and ( R )-chloroethylpyrrolidine 3 via O -alkylation. ( R )-Tertiary alcohol 2 was synthesized by stereoselective alkylation of chiral α-benzyloxy ketone with Grignard reagent via chelation-controlled 1,4-asymmetric induction. In the reaction, chiral benzyl group acts as a chiral auxiliary as well as a protecting group. ( R )-Chloroethylpyrrolidine 3 was prepared by asymmetric transformation starting with l -homoserine lactone, in which racemization-minimized N -allylation and ring-closing metathesis were involved as key steps.
Author Kim, Tae-Hyun
Jung, Jung Wha
Kim, Hee-Doo
Lee, Sun Young
Author_xml – sequence: 1
  givenname: Sun Young
  surname: Lee
  fullname: Lee, Sun Young
  organization: College of Pharmacy, Sookmyung Women’s University
– sequence: 2
  givenname: Jung Wha
  surname: Jung
  fullname: Jung, Jung Wha
  organization: College of Pharmacy, Sookmyung Women’s University
– sequence: 3
  givenname: Tae-Hyun
  surname: Kim
  fullname: Kim, Tae-Hyun
  organization: College of Pharmacy, Sookmyung Women’s University
– sequence: 4
  givenname: Hee-Doo
  surname: Kim
  fullname: Kim, Hee-Doo
  email: hdkim@sm.ac.kr
  organization: College of Pharmacy, Sookmyung Women’s University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26219510$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002056579$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkUFvFCEUgImpsdvVH-DFzLFNOsqDAYaT2TTaNmlisqlnQtk3K-0MrMAe9t_LOtWDh8rlXb6PF_jOyEmIAQl5D_QjUKo-ZWBMsZaCaKnsoO1ekQVoJVuuenlCFpQJ3kom9Sk5y_mRUi6FEG_IKZMMtAC6IJ9X-TBNWJJ3TT6E8gOzz00cmhtoEjrclZgaG4rdxuBzac7Xl-uL1o042Vx8wLfk9WDHjO-e55J8__rl_uqmvft2fXu1umtdB1DaTnBEx0Hy3lElBHP6QfENOMu4AznYATdDp52TA0dQVmsUTAPbMK7VoBlfkov53pAG8-S8idb_nttonpJZre9vDQCXfd20JOczu0vx5x5zMZPPDsfRBoz7bBg9nvp-9V-0In0PfadkRT88o_uHCTdml_xk08H8-csKwAy4FHNOOPxFgJpjLzP3MrWXOfYyXXXUP47zxRYfQ0nWjy-abDZz3RK2mMxj3KdQG7wg_QLof6Xo
CitedBy_id crossref_primary_10_1007_s10562_018_2406_4
crossref_primary_10_1016_j_ccr_2016_08_007
crossref_primary_10_3390_catal12070730
crossref_primary_10_3390_ijms252011158
crossref_primary_10_1002_ejoc_201800751
crossref_primary_10_1007_s00210_025_03978_3
crossref_primary_10_1039_D4MD01004C
Cites_doi 10.1055/s-0034-1380461
10.1080/00397919008053128
10.1002/chem.200501397
10.1007/BF02977320
10.1021/ol100627c
10.1038/nature07592
10.1016/j.tetasy.2011.11.005
10.1002/hlca.19760590721
10.1039/c39850001636
10.1016/S0040-4039(00)00031-9
10.1021/jo961189t
10.1016/j.tetasy.2008.06.007
10.1002/ejoc.201402935
10.1055/s-0033-1340163
10.1016/j.tet.2011.09.073
ContentType Journal Article
Copyright The Pharmaceutical Society of Korea 2015
Copyright_xml – notice: The Pharmaceutical Society of Korea 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ACYCR
DOI 10.1007/s12272-015-0641-4
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1976-3786
EndPage 2136
ExternalDocumentID oai_kci_go_kr_ARTI_1136845
26219510
10_1007_s12272_015_0641_4
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Sookmyung Women’s University Research Grants 2012
GroupedDBID ---
-53
-56
-5G
-BR
-EM
-Y2
-~C
.86
.UV
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2WC
2~H
30V
3SX
4.4
406
408
40D
40E
53G
5GY
5VS
67N
67Z
6J9
6NX
8TC
8UJ
95-
95.
95~
96X
9ZL
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACUDM
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
KVFHK
LLZTM
M4Y
MA-
MZR
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDE
SDH
SHX
SISQX
SJN
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z83
Z87
Z8O
Z8P
Z8Q
Z91
ZMTXR
ZOVNA
ZZE
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
AABYN
AAFGU
AAKSU
AAPBV
AAYFA
ABFGW
ABKAS
ACBMV
ACBRV
ACBYP
ACIGE
ACIPQ
ACTTH
ACVWB
ACWMK
ACYCR
ADMDM
ADOXG
AEEQQ
AEFTE
AESTI
AEVTX
AFAFS
AFNRJ
AGGBP
AGKHE
AIMYW
AJDOV
AKQUC
UNUBA
Z7X
ID FETCH-LOGICAL-c411t-453eec31638c07552c9b73d1ca23c16fafedf49cc6f3e17a99e52912d2397f923
IEDL.DBID AGYKE
ISSN 0253-6269
1976-3786
IngestDate Tue Nov 21 21:30:00 EST 2023
Wed Oct 01 14:31:27 EDT 2025
Wed Oct 01 14:30:35 EDT 2025
Wed Feb 19 01:57:57 EST 2025
Wed Oct 01 04:24:53 EDT 2025
Thu Apr 24 22:56:26 EDT 2025
Fri Feb 21 02:37:03 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Asymmetric synthesis
Asymmetric transformation
(
H
Clemastine
,
receptor antagonist
(R,R)-Clemastine
H1 receptor antagonist
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c411t-453eec31638c07552c9b73d1ca23c16fafedf49cc6f3e17a99e52912d2397f923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000010.2015.38.12.013
PMID 26219510
PQID 1738818476
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1136845
proquest_miscellaneous_2000009517
proquest_miscellaneous_1738818476
pubmed_primary_26219510
crossref_primary_10_1007_s12272_015_0641_4
crossref_citationtrail_10_1007_s12272_015_0641_4
springer_journals_10_1007_s12272_015_0641_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20151200
2015-12-00
2015-Dec
20151201
2015-12
PublicationDateYYYYMMDD 2015-12-01
PublicationDate_xml – month: 12
  year: 2015
  text: 20151200
PublicationDecade 2010
PublicationPlace Seoul
PublicationPlace_xml – name: Seoul
– name: Korea (South)
PublicationTitle Archives of pharmacal research
PublicationTitleAbbrev Arch. Pharm. Res
PublicationTitleAlternate Arch Pharm Res
PublicationYear 2015
Publisher Pharmaceutical Society of Korea
대한약학회
Publisher_xml – name: Pharmaceutical Society of Korea
– name: 대한약학회
References Jung, Ho, Kim (CR7) 2000; 41
Shimizu, Uetsu, Takahashi, Ito (CR14) 2015; 26
Fernández-Mateos, Marciá, Yus (CR3) 2014; 29
Sato, Kobayashi, Takahashi, Chiba, Takeda, Kusakabe (CR13) 1985; 22
Fournier, Brown, Farnaby, Miyatake-Ondozabal, Clayden (CR5) 2010; 12
Nelson, Williams, Thomas (CR11) 2002
CR16
Ebnöther, Weber (CR2) 1976; 59
Kim, Chang, Kim (CR9) 2011; 22
Chang, Kim, Kim (CR1) 2008; 19
Han, Wang, Wang (CR6) 2011; 67
Kim, Kim, Yang, Jung, Jeong, Kim (CR10) 2014; 25
Stymiest, Bagutski, French, Aggarwal (CR15) 2008; 456
Vanhessche, Sharpless (CR17) 1996; 61
Nikiforov, Stanchev, Milenkov, Dimitrov (CR12) 1990; 20
Jung, Kim (CR8) 2007; 30
Forrat, Prieto, Ramón, Yus (CR4) 2006; 12
T Nikiforov (641_CR12) 1990; 20
WL Nelson (641_CR11) 2002
JE Jung (641_CR7) 2000; 41
E Fernández-Mateos (641_CR3) 2014; 29
K Shimizu (641_CR14) 2015; 26
TH Kim (641_CR10) 2014; 25
M Chang (641_CR1) 2008; 19
A Ebnöther (641_CR2) 1976; 59
JW Jung (641_CR8) 2007; 30
F Sato (641_CR13) 1985; 22
JL Stymiest (641_CR15) 2008; 456
SJ Kim (641_CR9) 2011; 22
641_CR16
KPM Vanhessche (641_CR17) 1996; 61
AM Fournier (641_CR5) 2010; 12
P Han (641_CR6) 2011; 67
VJ Forrat (641_CR4) 2006; 12
References_xml – volume: 26
  start-page: 1238
  year: 2015
  end-page: 1242
  ident: CR14
  article-title: Zn(salen)-catalyzed enantioselective phenyl transfer to aldehydes and ketones with organozinc reagent
  publication-title: Synlett
  doi: 10.1055/s-0034-1380461
– volume: 20
  start-page: 1977
  year: 1990
  end-page: 1981
  ident: CR12
  article-title: A route to optically active benzyl ester of (1-methyl-2-pyrrolidinyl)acetic acid, an intermediate in the synthesis of clemastine
  publication-title: Synthetic Communications
  doi: 10.1080/00397919008053128
– volume: 12
  start-page: 4431
  year: 2006
  end-page: 4445
  ident: CR4
  article-title: -1-Sufonylamino-2-isoborneolsulfonylaminocyclohexane derivatives: Excellent chiral ligands for catalytic enantioselective addition of organozinc reagents to ketones
  publication-title: Chemistry-A European Journal
  doi: 10.1002/chem.200501397
– volume: 30
  start-page: 1521
  year: 2007
  end-page: 1525
  ident: CR8
  article-title: Stereoselective synthesis of (–)-hydroxyclemastine as a versatile intermediate for the H receptor antagonist clemastine
  publication-title: Archives of Pharmacal Research
  doi: 10.1007/BF02977320
– volume: 12
  start-page: 2222
  year: 2010
  end-page: 2225
  ident: CR5
  article-title: Synthesis of (–)-( , )-clemastine by invertive N → C aryl migration in lithiated carbamate
  publication-title: Organic Letters
  doi: 10.1021/ol100627c
– volume: 456
  start-page: 778
  year: 2008
  end-page: 783
  ident: CR15
  article-title: Enantiodivergent conversion of chiral secondary alcohols into tertiary alcohols
  publication-title: Nature
  doi: 10.1038/nature07592
– ident: CR16
– volume: 22
  start-page: 1901
  year: 2011
  end-page: 1905
  ident: CR9
  article-title: Asymmetric transformation of -homoserine lactone to an optically active 2-substituted pyrrolidine for clemastine
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2011.11.005
– volume: 59
  start-page: 2462
  year: 1976
  end-page: 2468
  ident: CR2
  article-title: Synthesis and absolute configuration of clemastine and its isomers
  publication-title: Helvetica Chimica Acta
  doi: 10.1002/hlca.19760590721
– volume: 22
  start-page: 1636
  year: 1985
  end-page: 1638
  ident: CR13
  article-title: Synthesis of the rarely obtained -adducts in the reaction of organocopper compounds with 2,3- -isopropylideneglyceraldehyde. Preparation of optically active epoxy alcohols
  publication-title: Journal of the Chemical Society, Chemical Communications
  doi: 10.1039/c39850001636
– volume: 41
  start-page: 1793
  year: 2000
  end-page: 1796
  ident: CR7
  article-title: Bidentate chelation-controlled asymmetric synthesis of α-hydroxy esters based on the glycolate enolate alkylation
  publication-title: Tetrahedron Letters
  doi: 10.1016/S0040-4039(00)00031-9
– start-page: 794
  year: 2002
  end-page: 818
  ident: CR11
  article-title: Antihistamines and related antiallergic and antiulcer agents
  publication-title: Foye’s principles of medicinal chemistry
– volume: 61
  start-page: 7978
  year: 1996
  end-page: 7979
  ident: CR17
  article-title: Ligand-dependent reversal of facial selectivity in asymmetric dihydroxylation
  publication-title: Journal of Organic Chemistry
  doi: 10.1021/jo961189t
– volume: 19
  start-page: 1503
  year: 2008
  end-page: 1507
  ident: CR1
  article-title: Stereoselective synthesis of (+)-flutriafol
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2008.06.007
– volume: 29
  start-page: 6519
  year: 2014
  end-page: 6526
  ident: CR3
  article-title: Catalytic enantioselective addition of aryl Grignard reagents to ketones
  publication-title: European Journal of Organic Chemistry
  doi: 10.1002/ejoc.201402935
– volume: 25
  start-page: 251
  year: 2014
  end-page: 254
  ident: CR10
  article-title: A chiral benzyl group as a chiral auxiliary and protecting group for the synthesis of optically active 1,2-diols and (+)-frontalin
  publication-title: Synlett
  doi: 10.1055/s-0033-1340163
– volume: 67
  start-page: 8873
  year: 2011
  end-page: 8878
  ident: CR6
  article-title: Electronic polarizability-based stereochemical model for Sharpless AD reactions
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2011.09.073
– volume: 20
  start-page: 1977
  year: 1990
  ident: 641_CR12
  publication-title: Synthetic Communications
  doi: 10.1080/00397919008053128
– volume: 67
  start-page: 8873
  year: 2011
  ident: 641_CR6
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2011.09.073
– volume: 41
  start-page: 1793
  year: 2000
  ident: 641_CR7
  publication-title: Tetrahedron Letters
  doi: 10.1016/S0040-4039(00)00031-9
– volume: 59
  start-page: 2462
  year: 1976
  ident: 641_CR2
  publication-title: Helvetica Chimica Acta
  doi: 10.1002/hlca.19760590721
– volume: 61
  start-page: 7978
  year: 1996
  ident: 641_CR17
  publication-title: Journal of Organic Chemistry
  doi: 10.1021/jo961189t
– volume: 19
  start-page: 1503
  year: 2008
  ident: 641_CR1
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2008.06.007
– volume: 456
  start-page: 778
  year: 2008
  ident: 641_CR15
  publication-title: Nature
  doi: 10.1038/nature07592
– volume: 29
  start-page: 6519
  year: 2014
  ident: 641_CR3
  publication-title: European Journal of Organic Chemistry
  doi: 10.1002/ejoc.201402935
– volume: 22
  start-page: 1901
  year: 2011
  ident: 641_CR9
  publication-title: Tetrahedron Asymmetry
  doi: 10.1016/j.tetasy.2011.11.005
– start-page: 794
  volume-title: Foye’s principles of medicinal chemistry
  year: 2002
  ident: 641_CR11
– volume: 12
  start-page: 4431
  year: 2006
  ident: 641_CR4
  publication-title: Chemistry-A European Journal
  doi: 10.1002/chem.200501397
– volume: 25
  start-page: 251
  year: 2014
  ident: 641_CR10
  publication-title: Synlett
  doi: 10.1055/s-0033-1340163
– volume: 22
  start-page: 1636
  year: 1985
  ident: 641_CR13
  publication-title: Journal of the Chemical Society, Chemical Communications
  doi: 10.1039/c39850001636
– volume: 26
  start-page: 1238
  year: 2015
  ident: 641_CR14
  publication-title: Synlett
  doi: 10.1055/s-0034-1380461
– volume: 12
  start-page: 2222
  year: 2010
  ident: 641_CR5
  publication-title: Organic Letters
  doi: 10.1021/ol100627c
– volume: 30
  start-page: 1521
  year: 2007
  ident: 641_CR8
  publication-title: Archives of Pharmacal Research
  doi: 10.1007/BF02977320
– ident: 641_CR16
SSID ssj0036555
Score 2.138022
Snippet The first asymmetric synthesis of ( R , R )-clemastine ( 1 ) has been accomplished by the coupling of ( R )-tertiary alcohol 2 and ( R )-chloroethylpyrrolidine...
The first asymmetric synthesis of (R,R)-clemastine (1) has been accomplished by the coupling of (R)-tertiary alcohol 2 and (R)-chloroethylpyrrolidine 3 via...
SourceID nrf
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2131
SubjectTerms alcohols
alkylation
antagonists
Chemistry, Pharmaceutical - methods
Clemastine - chemical synthesis
Histamine H1 Antagonists - chemical synthesis
Medicine
Pharmacology/Toxicology
Pharmacy
Receptors, Histamine H1 - chemistry
Research Article
Stereoisomerism
약학
Title Asymmetric synthesis of H1 receptor antagonist (R,R)-clemastine
URI https://link.springer.com/article/10.1007/s12272-015-0641-4
https://www.ncbi.nlm.nih.gov/pubmed/26219510
https://www.proquest.com/docview/1738818476
https://www.proquest.com/docview/2000009517
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002056579
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Archives of Pharmacal Research, 2015, 38(12), , pp.2131-2136
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AFBBN
  dateStart: 19970201
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-WFMZe9tF9uduCNkbZR1wsybLjp5GOZtlGSykJtE9ClqVS0tglTh6yv34nfzRsawd9ysvFlnWnu99xp98BvKeJ4jYSymd6kPqhCJTvphT6JkhToQ1LM-YuJx8eReNp-ONUnDb3uMu2270tSVaeenPZjbHYtREIH8MoJj4d2BIuP-nC1vDb2c-D1gHzSFTDTjGacx_xetIWM296yB_hqJMv7E1I858qaRV8Ro9g0i677jmZ7a2W6Z7-9Rej4x2_6zE8bMAoGdbW8wTumXwb7h825fZt2D2uia3XfTLZ3NMq-2SXHG8or9dP4cuwXM_nbjiXJuU6R1BZXpSksGRMCbpUc4WZPUEdqvPCMfWSDyf9k48-vnOu0MXk5hlMRweTr2O_Gc3g65DSJSqVG6O5A3MaQYdgOkljnlGtGNc0ssqazIaJ1pHlhsYqSYxgCWUZQ_xjEVQ-h25e5OYlkChgCt1KjNCLh2GmFVcBChurA50qyj0IWg1J3fCWu_EZl3LDuOx2UOIOSreDMvTg0_VfrmrSjv8Jv0O1y5m-kI5q2_2eF3K2kJhQfJdu5M0gFB68ba1C4vlzRRWVm2JVShrzAYKeMI5ul2FVKoZYNvbgRW1S1-tiEcYMdIwefG7NQzZupLx90Tt3kn4FD5izr6oL5zV0l4uVeYNYapn28OyM9vePes0Z6kFnyoa_AaLVEyQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB7RVAIuPAoU81wQqoBmK-_DrxOKUEtKm6qqUqmcVuv1uqpC7CpODuHXM-tHI6BF6smXsb3eGc98q5n5BuADS7TIw0BTbuKUysDX1E0ppNZP08BYnmbcNSePjsLhqfx-Fpy1fdxVV-3epSRrT71qduM8cmUEAcUwigefNViXLI5lD9YH334c7HYOWIRBPewUo7mgiNeTLpl53UP-CEdrxSy_Dmn-kyWtg8_eQxh3y25qTiY7i3m6Y379xeh4y-96BA9aMEoGjfU8hju22IC7ozbdvgFbxw2x9bJPxqs-rapPtsjxivJ6-QS-DKrldOqGcxlSLQsEldVFRcqcDBlBl2ov8WRPUIf6vHRMveTjSf_kE8V3TjW6mMI-hdO93fHXIW1HM1AjGZujUoW1RjgwZxB0BNwkaSQyZjQXhoW5zm2Wy8SYMBeWRTpJbMATxjOO-CdHUPkMekVZ2OdAQp9rdCsRQi8hZWa00D4K29z4JtVMeOB3GlKm5S134zN-qhXjsttBhTuo3A4q6cHnq1suG9KO_wm_R7WriblQjmrbXc9LNZkpPFDsKzfyJpaBB-86q1D4_7mkii5suagUi0SMoEdG4c0yvD6KIZaNPNhsTOpqXTzEmIGO0YPtzjxU60aqmxf94lbSb-HecDw6VIf7Rwcv4T53tlZX5LyC3ny2sK8RV83TN-1_9BuowROw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9sheKLaP2Kn6tIUXtLs1_J5UkO9biqLUfpQd-WzWa3lHrJcbk-3H_vbD56iK3gU14myTKzO_MbZuc3AO9ZZoRPlKHcDnMqVWxomFJIXZznyjqeFzw0Jx8dJ5OZ_H6mzro5p3V_270vSbY9DYGlqVwdLAp_sGl84zwNVwoUxZCKSdAW3JUYqkP2NeOj3hWLRDVjTzGuC4rIPevLmjd94o_AtFUu_U2Y8696aROGxg_gfocfyag1-EO448pd2DnqKuS7sDdtuajXA3K6aa2qB2SPTDcs1etH8HlUr-fzME_LknpdIg6sL2pSeTJhBL2gW2AyTlDt5rwK5Lrkw8ng5CPFf84NeoXSPYbZ-NvplwntpilQKxlboR2Ec1YE_GURJyhuszwVBbOGC8sSb7wrvMysTbxwLDVZ5hTPGC84QhaPOPAJbJdV6Z4BSWJu0BOkiJaElIU1wsQo7LyNbW6YiCDuValtRzUeJl780huS5KB9jdrXQftaRvDp-pVFy7PxL-F3aB99aS90YMcOz_NKXy415gCHOkypGUoVwdvefBqPTKiDmNJVV7VmqRgiTpFpcrsMb7InhJ9pBE9b21-viyfo5tGXRbDfbwbdnfz69kU__y_pN7Az_TrWPw-Pf7yAezxs0-YOzUvYXi2v3CtEQqv8dbPbfwN0ZPsj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Asymmetric+synthesis+of+H1+receptor+antagonist+%28R%2CR%29-clemastine&rft.jtitle=Archives+of+pharmacal+research&rft.au=Lee%2C+Sun+Young&rft.au=Jung%2C+Jung+Wha&rft.au=Kim%2C+Tae-Hyun&rft.au=Kim%2C+Hee-Doo&rft.date=2015-12-01&rft.issn=0253-6269&rft.volume=38&rft.issue=12&rft.spage=2131&rft_id=info:doi/10.1007%2Fs12272-015-0641-4&rft_id=info%3Apmid%2F26219510&rft.externalDocID=26219510
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon